- BioNTech Boosts German Investment With Expansion of Vaccine Hubby superadminBioNTech SE has completed construction at a German facility for making a key ingredient in its messenger-RNA vaccines, the sort of investment that pharma leaders fear is becoming less attractive in Europe.
- Pfizer is expecting its covid windfall to end in 2023by superadminBefore 2020, vaccines would hardly bring riches to their makers. Then covid happened, and for the pharmaceutical companies that came up with vaccines against it, in particular Pfizer and Moderna, it was a bonanza. Billions of people globally needed one—no, two; actually, three; or four!—shots. Governments…
- InstaDeep’s acquisition is a classic case of an African startup gone globalby superadminThis January, Germany’s largest vaccine maker BioNTech announced that it had agreed to acquire Tunisian-born and London-headquartered AI startup InstaDeep for up to £562 million, including a performance-tied £200 million tranche investment. InstaDeep’s deal — subject to regulatory approval and expected to close in the first half of this year — is quite intriguing…
- Biden to End COVID Emergencies in Mayby superadminDoing so will have many effects, including the end of free vaccines and health services to fight the pandemic. The public health emergency has been renewed every 90 days since first being declared by the Trump administration in January 2020…
- Why pregnancy forums are rife with health misinformationby superadminOnline pregnancy support groups are teeming with vaccine misinformation. We asked experts what can be done…
- A vaccine sanctuary in the lymph node | Scienceby superadminB cell follicles in the lymph node protect vaccines to enhance immune responses…
- The COVID Vaccine Strategy in the US Could Look Very Different by Next Yearby superadminBivalent shots—and a single annual dose—may eventually become the norm…
© Copyright 2023 myClinApps | Powered by Team Lisaiceland